Data / Form D filings / C2N Diagnostics, LLC
C2N Diagnostics, LLC: Form D filings
C2N Diagnostics, LLC, a biotechnology company in St. Louis, MO, filed 3 Form D notices with the SEC between 2024 and 2025. The latest, on May 30, 2025, reports $10 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4340 DUNCAN AVENUE, St. Louis, MO, 63110
- Phone
- (877) 226-3424
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2021597
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | New notice | $9,999,891 | $9,999,891 | 1 | May 12, 2025 | sec.gov | |
| Sep 26, 2024 | Amendment | $24,999,618 | $24,999,618 | 3 | Mar 1, 2024 | sec.gov | |
| May 6, 2024 | New notice | $15,000,000 | $7,500,000 | $7,500,000 | 1 | Mar 1, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fred Miller | Director | |
| Dr. Michael Goldblatt | Director | |
| Micah Onixt | Executive Officer | |
| Dr. David Holtzman | Director | |
| Dr. Randall Bateman | Director | |
| Dr. Joel Braunstein | Executive Officer, Director |
Every Form D from the week of May 26, 2025 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what C2N Diagnostics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.